Developing effective payment platforms for accessing public finance in Zambia: Presentation and Q&A with Dr Kajal

Developing effective payment platforms for accessing public finance in Zambia: Presentation and Q&A with Dr Kajal

Dr. Kajal shares with us findings and lessons learnt from her research in Zambia that looked at developing effective payment platforms for accessing public finance. This was qualitative research with different stakeholders from the Churches Health Association of Zambia (CHAZ) and public sector ministry of health at state and provincial levels. The findings may be relevant to Low and Middle income countries such as India.

Speaker

Dr. Kajal

k

Affiliation

IAS Officer

Date

06-September-2018

Time

2.30 pm – 3.30 pm

Venue

Institute of Public Health, Bengaluru
#250, 2nd C Main, 2nd C Cross,
Girinagar Ist  Phase,
Bengaluru – 560085

Ninth Webinar in the Epilogue Series

Ninth Webinar in the Epilogue Series

Closing the Gap: Health Equity Research Initiative in India of the Achutha Menon Centre for Health Science Studies, Sree Chitra Tirunal Institute for Medical Sciences and Technology is partnering with the Cluster on Health Equity at the Institute of Public Health Bengaluru to announce the ninth webinar in the Equilogues series.

Theme: Denial of reproductive health rights of Particularly Vulnerable Tribal Groups (PVTGs) in Chhattisgarh

Speaker: Sulakshana Nandi, State Convener of Public Health Resource Network, Chhattisgarh.

k

Affiliation

Public Health Resource Network

Date

30-Aug-2018

Time

11.00 Am – 12.00 pm

Venue

Institute of Public health #250, 2nd C Main, 2nd C Cross, Girinagar Ist  Phase, Bengaluru – 560085
Review Methods

Review Methods

This seminar is structured differently. 3 speakers (Prashanth, Tanya and Nityasri) will make presentations of 15 minutes each on related topics. All research begins with a review of literature. In this seminar, the three speakers will each present a different review method – realist synthesis, critical interpretative synthesis and systematic review, respectively.

Speaker

Prashanth, Tanya and Nityasri

k

Affiliation

IPH Staff

Date

23-August-2018

Time

4.00 pm – 5.00 pm

Venue

Institute of Public Health, Bengaluru
#250, 2nd C Main, 2nd C Cross,
Girinagar Ist  Phase,
Bengaluru – 560085

The Blind Men and the Elephant: India’s Tuberculosis epidemic

The Blind Men and the Elephant: India’s Tuberculosis epidemic

The seminar will discuss my observations about India’s tuberculosis epidemic, seen through the perspective of my training in infectious diseases and microbiology. I have spent the last year working with the National Institute of Research in Tuberculosis on a research project that aimed at using protoemic methods to identify drug-resistance in TB. I spent a month in Mumbai, at the P.D. Hinduja hospital with Dr Camilla Rodrigues and Dr Zarir Udwadia, both world authorities on the microbiology and clinical management, respectively, of MDR-TB. Lastly, I visted hospitals and laboratories in rural India to try to understand their challenges with the diagnosis and management of TB.

Speaker

Husain Poonawala

k

Affiliation

IPH Adjunct Faculty

Date

22-August-2018

Time

4.00 pm – 5.00 pm

Venue

Institute of Public Health, Bengaluru
#250, 2nd C Main, 2nd C Cross,
Girinagar Ist  Phase,
Bengaluru – 560085

Implementation research for taking tobacco control policy interventions to scale in India

Implementation research for taking tobacco control policy interventions to scale in India

Tobacco kills approximately six million people globally and over one million adults in India each year. In India, a comprehensive tobacco control law the Cigarettes and Other Tobacco Products Act (COTPA) 2003 exists. However, the implementation remains sub-optimal. COTPA has worked in some places/contexts/settings and not in others. From a policy and implementation perspective, it is crucial to systematically understand how and why the implementation of this law has occurred. By doing this, we will improve our knowledge of implementing effective tobacco control policies (TCPs) as well as identify system-wide implementation bottlenecks that could affect other sectors like pharmaceutical/food. I aim to improve the implementation of TCP in India by describing and explaining the why and how of its implementation across Indian states. Some of the hypotheses include: a) Champions at either political or bureaucratic level facilitate policy making and implementation process b) Implementation is weakened when restrictive mandates are provided to departments who are not involved in punitive action. The study will be conducted in five phases using quantitative and qualitative methods to map implementation landscape and using theory-driven inquiry to draw lessons. The purpose of this seminar is to seek suggestions to improve the proposal and shape the work that I will be doing over the next 5 years as part of my early career India Alliance fellowship.

Speaker

Pragati Hebbar

k

Affiliation

IPH Staff

Date

16-August-2018

Time

4.00 pm – 5.00 pm

Venue

Institute of Public Health, Bengaluru
#250, 2nd C Main, 2nd C Cross,
Girinagar Ist  Phase,
Bengaluru – 560085

Deciphering an epidemic of epic proportion: the role of state and tobacco industry in tobacco control in post-liberalized India (1990-2017)

Deciphering an epidemic of epic proportion: the role of state and tobacco industry in tobacco control in post-liberalized India (1990-2017)

In this seminar, Upendra Bhojani will present an overview of the research he aims to conduct as part of the India Alliance fellowship for the next 5 years. The purpose is to seek comments/suggestions/critique for refining the proposal. About 3500 Indians die every day due to tobacco-attributable illnesses. Despite several regulatory measures, there has been a marginal decline in tobacco use in the last two decades. In fact, since 1990s, tobacco production and sales have increased. Therefore, this research aims to understand the role played by the state policies (related to tobacco) and the tobacco industry actions during 1990-2017. I will conduct the study in three phases. In Phase-1, I will map public policies related to tobacco in this period. In will use quantitative data to explore associations between the tobacco policies and the trends in tobacco production and consumption. In phase-2 I will use qualitative data to understand how the tobacco industry actors influence tobacco policies in India. How do governments in India respond to the industry influence as well as their own varying (often conflicting) interests in tobacco? Based on these insights, in the phase-3, I will select ten Indian states: five positive (significant decline in tobacco prevalence over time) and five negative (status quo or increase in tobacco prevalence) cases. I will use qualitative comparative analysis to understand the combinations of measures (policies, implementation, tobacco industry) that best explain a significant reduction in tobacco use prevalence.

Speaker

Upendra Bhojani

k

Affiliation

IPH Staff

Date

09-August-2018

Time

4.00 pm – 5.00 pm

Venue

Institute of Public Health, Bengaluru
#250, 2nd C Main, 2nd C Cross,
Girinagar Ist  Phase,
Bengaluru – 560085

Deciphering an epidemic of epic proportion

In this seminar, Upendra Bhojani will present an overview of the research he aims to conduct as part of the India Alliance fellowship for the next 5 years. The purpose is to seek comments/suggestions/critique for refining the proposal.

About 3500 Indians die every day due to tobacco-attributable illnesses. Despite several regulatory measures, there has been a marginal decline in tobacco use in the last two decades. In fact, since 1990s, tobacco production and sales have increased. Therefore, this research aims to understand the role played by the state policies (related to tobacco) and the tobacco industry actions during 1990-2017.

Upendra will conduct the study in three phases. In Phase-1, he will map public policies related to tobacco in this period. In will use quantitative data to explore associations between the tobacco policies and the trends in tobacco production and consumption. In phase-2 he will use qualitative data to understand how the tobacco industry actors influence tobacco policies in India. How do governments in India respond to the industry influence as well as their own varying (often conflicting) interests in tobacco? Based on these insights, in the phase-3, he will select ten Indian states: five positive (significant decline in tobacco prevalence over time) and five negative (status quo or increase in tobacco prevalence) cases. He will use qualitative comparative analysis to understand the combinations of measures (policies, implementation, tobacco industry) that best explain a significant reduction in tobacco use prevalence.

Speaker

Upendra Bhojani

k

Affiliation

Institute of Public Health, Bengaluru

Date

9-Aug-2018

Time

4.00 pm – 5.00 pm

Venue

Institute of Public health
#250, 2nd C Main, 2nd C Cross,
Girinagar Ist  Phase,
Bengaluru – 560085

A Comparison of National Guidelines

A Comparison of National Guidelines

Visceral Leishmaniasis (VL) is an infectious disease predominantly transmitted by the sandfly. 90% of the cases of VL in the world occur in Brazil, Ethiopia, South Sudan, Sudan, India, Nepal, and Bangladesh. In 2005, the WHO South East Asia Region, responding to increasing incidences of VL in the Indian subcontinent, initiated a VL elimination program within India, Bangladesh, and Nepal. The aim was to reduce the incidence of VL to <1 case per 10,000 cases in districts/subdistricts within the three countries by 2015. Since then, the goalposts have shifted from 2015 to 2017 and, now, to 2020. Nepal and Bangladesh have traveled much further on the road to elimination than India has, Nepal having sustained the elimination target in the 12 once-endemic districts since 2012. In 2016, Bangladesh reached the elimination target in 99% of its endemic subdistricts (upazilas). Lagging closely behind, India has reached the elimination target in 85% of endemic subdistricts. The aim of this literature review predominantly on the national guidelines of VL elimination/control in the three countries as well as some research articles on the same is to compare the program in India with Bangladesh and Nepal, to identify similarities and differences between the programs, and to extrapolate data to see how India can learn from Bangladesh and Nepal to hasten its pace towards elimination of VL.

Speaker

Sayema

k

Affiliation

IPH Intern

Date

03-August-2018

Time

4.00 pm – 5.00 pm

Venue

Institute of Public Health, Bengaluru
#250, 2nd C Main, 2nd C Cross,
Girinagar Ist  Phase,
Bengaluru – 560085

GIS Mapping

GIS Mapping

There is very little information currently available about the private sector in India. This project aimed to develop a profile of all the private sector medical facilities in the state of Karnataka, particularly in the context of the recently announced Aarogya Karnataka scheme by the Government of Karnataka.GIS Mapping of Private Sector Medical Facilities in Karnataka.

Speaker

Eunice Choi

k

Affiliation

IPH Intern

Date

03-August-2018

Time

3.00 pm – 4.00 pm

Venue

Institute of Public Health, Bengaluru
#250, 2nd C Main, 2nd C Cross,
Girinagar Ist  Phase,
Bengaluru – 560085

Tobacco Control Project

Tobacco Control Project

Understanding public policy around tobacco use is required to understand the conflicts of interests of state and non-state actors in India. My work revolved around mapping concerns on tobacco expressed as debates by the parliamentary elected representatives by sourcing the official archives of loksabha and rajyasabha.

Speaker

Chaitra

k

Affiliation

IPH Intern

Date

01-August-2018

Time

4.00 pm – 5.00 pm

Venue

Institute of Public Health, Bengaluru
#250, 2nd C Main, 2nd C Cross,
Girinagar Ist  Phase,
Bengaluru – 560085